Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009-2019)

CONCLUSION: In France, ATTRv patients are usually identified early thanks to the national network and the help of diagnosis combining genetic testing and mini-invasive biopsies.PMID:38643028 | DOI:10.1016/j.neurol.2024.02.393

Source: Revue Neurologique - April 20, 2024 Category: Neurology Authors: D Adams P Cintas G Sol é C Tard C Labeyrie A Echaniz-Laguna C Cauquil Y Pereon L Magy R Juntas Morales J C Antoine E Lagrange P Petiot M Mallaret B Francou A Guiochon-Mantel A Coste O Demarcq C Geffroy V Famelart J Rudant M Bartoli E Donal O Lairez J C E Source Type: research